Journal Article

Three-year duration of benefit from abciximab in patient receiving stents for acute myocardial infarction in the randomized double-blind ADMIRAL study

Jaime Dominguez and Balavenkatesh Kanna

in European Heart Journal

Published on behalf of European Society of Cardiology

Volume 27, issue 12, pages 1508-1509
Published in print June 2006 | ISSN: 0195-668x
Published online May 2006 | e-ISSN: 1522-9645 | DOI: https://dx.doi.org/10.1093/eurheartj/ehl008
Three-year duration of benefit from abciximab in patient receiving stents for acute myocardial infarction in the randomized double-blind ADMIRAL study

Show Summary Details

Journal Article.  279 words. 

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.